UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study

Targeted oncology, 2016-04, Vol.11 (2), p.157-166

2016

Volltextzugriff (PDF)

Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: A review of existing evidence

Critical reviews in oncology/hematology, 2012-08, Vol.83 (2), p.208-215

2012

Volltextzugriff (PDF)

Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM)

ESMO open, 2024-02, Vol.9 (2), p.102243-102243, Article 102243

2024

Volltextzugriff (PDF)

203P Treatment patterns and real-world outcomes of extensive-stage small cell lung cancer: A retrospective, multicenter study

ESMO open, 2024-03, Vol.9, p.102776, Article 102776

2024

Volltextzugriff (PDF)

Next Generation Sequencing (Ngs) Reveals Qualitative and Quantitative Molecular Heterogeneity Within Egfr-Mutant Advanced Lung Adenocarcinoma (Ala) Patients (Pts) Receiving Gefitinib (G)

Annals of oncology, 2014-09, Vol.25, p.iv462

2014

Volltextzugriff (PDF)

A Randomized Phase III Multicenter Trial of Customized Chemotherapy Versus Standard of Care for 1St Line Treatment of Elderly Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc): the Elderly Patient Individualized Chemotherapy (Epic) Trial

Annals of oncology, 2014-09, Vol.25, p.iv467

2014

Volltextzugriff (PDF)

Be-Positive: Beyond Progression After Tyrosine Kinase Inhibitor in Egfr-Positive Non-Small Cell Lung Cancer (Nsclc) Patients. Preliminary Results from a Multicenter Italian Observational Study

Annals of oncology, 2014-09, Vol.25, p.iv450

2014

Volltextzugriff (PDF)

Role of afatinib in the treatment of advanced lung squamous cell carcinoma

Clinical pharmacology: advances and applications, 2017-01, Vol.9, p.147-157

Vavala, Tiziana

2017

Volltextzugriff (PDF)

Retrospective Study of Radiological Findings of Pulmonary Embolisms (PE) in Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC)

Annals of oncology, 2012-09, Vol.23, p.ix444

2012

Volltextzugriff (PDF)

Peritoneal carcinomatosis in non-small celllung cancer: retrospective multicentric analysis

Annals of oncology, 2016-09, Vol.27, p.iv14

2016

Volltextzugriff (PDF)

P1.14-04 Final Results of the Prospective Genomics of Young Lung Cancer (GYLC), an Addario Lung Cancer Medical Institute Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S553-S553

2019

Volltextzugriff (PDF)

P2.04-14 NLR, dNLR and PLR as Possible Predictive Markers in Patients with NSCLC Treated with ICI

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S713-S713

2019

Volltextzugriff (PDF)

1311PNEXT GENERATION SEQUENCING (NGS) REVEALS QUALITATIVE AND QUANTITATIVE MOLECULAR HETEROGENEITY WITHIN EGFR-MUTANT ADVANCED LUNG ADENOCARCINOMA (ALA) PATIENTS (PTS) RECEIVING GEFITINIB (G)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv462-iv462

2014

Volltextzugriff (PDF)

IASLC-4 General trends and ongoing studies of lung cancer in Italy

Japanese Journal of Lung Cancer, 2012-10, Vol.52 (5), p.480-481

2012

Volltextzugriff (PDF)

1278PBE-POSITIVE: BEYOND PROGRESSION AFTER TYROSINE KINASE INHIBITOR IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS. PRELIMINARY RESULTS FROM A MULTICENTER ITALIAN OBSERVATIONAL STUDY

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv450-iv450

2014

Volltextzugriff (PDF)

1329TiPA RANDOMIZED PHASE III MULTICENTER TRIAL OF CUSTOMIZED CHEMOTHERAPY VERSUS STANDARD OF CARE FOR 1ST LINE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): THE ELDERLY PATIENT INDIVIDUALIZED CHEMOTHERAPY (EPIC) TRIAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv467-iv467

2014

Volltextzugriff (PDF)

Gastrointestinal opportunistic infections and human immunodeficiency virus (HIV). Case report

Il Giornale di chirurgia, 2007-06, Vol.28 (6-7), p.270-273

2007

Volltextzugriff (PDF)

Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus

Rheumatology (Oxford, England), 2014-03, Vol.53 (3), p.465-472

2014

Volltextzugriff (PDF)

SC10.04 Second-Line Therapy and Beyond in Squamous Cell NSCLC

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S101-S102

2017

Volltextzugriff (PDF)

Role of afatinib in the treatment of advanced lung squamous cell carcinoma

Clinical pharmacology: advances and applications, 2017-01, Vol.9, p.147

Vavala, Tiziana

2017

Volltextzugriff (PDF)

The 6-joint ultrasonographic assessment: a valid, sensitive-to-change and feasible method for evaluating joint inflammation in RA

Rheumatology (Oxford, England), 2012-05, Vol.51 (5), p.866-873

2012

Volltextzugriff (PDF)

The interobserver reliability of ultrasound in knee osteoarthritis

Rheumatology (Oxford, England), 2012-11, Vol.51 (11), p.2013-2019

2012

Volltextzugriff (PDF)

Editorial: Brain and leptomeningeal metastases in lung cancer

Frontiers in oncology, 2023-01, Vol.12, p.1115126-1115126

2023

Volltextzugriff (PDF)

Adolescents may accurately self-collect pharyngeal and rectal clinical specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infection

PloS one, 2021-09, Vol.16 (9), p.e0255878-e0255878

2021

Volltextzugriff (PDF)

Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer

International journal of molecular sciences, 2021-11, Vol.22 (21), p.11942

2021

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(162)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(58)
Humans
(50)
Female
(28)
Oncology
(27)
Male
(21)
Adult
(15)
Middle Aged
(14)
United States
(14)
Aged
(13)
Health Administration
(13)
Lung Cancer
(13)
Lung Neoplasms - Drug Therapy
(11)
Pharmacology & Pharmacy
(11)
Mutation
(10)
Old Medline
(10)
Technology
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Ultrasound
(9)
Non-Small Cell Lung Cancer
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study

Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: A review of existing evidence

Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM)

203P Treatment patterns and real-world outcomes of extensive-stage small cell lung cancer: A retrospective, multicenter study

Next Generation Sequencing (Ngs) Reveals Qualitative and Quantitative Molecular Heterogeneity Within Egfr-Mutant Advanced Lung Adenocarcinoma (Ala) Patients (Pts) Receiving Gefitinib (G)

A Randomized Phase III Multicenter Trial of Customized Chemotherapy Versus Standard of Care for 1St Line Treatment of Elderly Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc): the Elderly Patient Individualized Chemotherapy (Epic) Trial

Be-Positive: Beyond Progression After Tyrosine Kinase Inhibitor in Egfr-Positive Non-Small Cell Lung Cancer (Nsclc) Patients. Preliminary Results from a Multicenter Italian Observational Study

Role of afatinib in the treatment of advanced lung squamous cell carcinoma

Retrospective Study of Radiological Findings of Pulmonary Embolisms (PE) in Patients (PTS) with Advanced Non-Small Cell Lung Cancer (NSCLC)

Peritoneal carcinomatosis in non-small celllung cancer: retrospective multicentric analysis

P1.14-04 Final Results of the Prospective Genomics of Young Lung Cancer (GYLC), an Addario Lung Cancer Medical Institute Study

P2.04-14 NLR, dNLR and PLR as Possible Predictive Markers in Patients with NSCLC Treated with ICI

1311PNEXT GENERATION SEQUENCING (NGS) REVEALS QUALITATIVE AND QUANTITATIVE MOLECULAR HETEROGENEITY WITHIN EGFR-MUTANT ADVANCED LUNG ADENOCARCINOMA (ALA) PATIENTS (PTS) RECEIVING GEFITINIB (G)

IASLC-4 General trends and ongoing studies of lung cancer in Italy

1278PBE-POSITIVE: BEYOND PROGRESSION AFTER TYROSINE KINASE INHIBITOR IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS. PRELIMINARY RESULTS FROM A MULTICENTER ITALIAN OBSERVATIONAL STUDY

1329TiPA RANDOMIZED PHASE III MULTICENTER TRIAL OF CUSTOMIZED CHEMOTHERAPY VERSUS STANDARD OF CARE FOR 1ST LINE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): THE ELDERLY PATIENT INDIVIDUALIZED CHEMOTHERAPY (EPIC) TRIAL

Gastrointestinal opportunistic infections and human immunodeficiency virus (HIV). Case report

Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus

SC10.04 Second-Line Therapy and Beyond in Squamous Cell NSCLC

Role of afatinib in the treatment of advanced lung squamous cell carcinoma

The 6-joint ultrasonographic assessment: a valid, sensitive-to-change and feasible method for evaluating joint inflammation in RA

The interobserver reliability of ultrasound in knee osteoarthritis

Editorial: Brain and leptomeningeal metastases in lung cancer

Adolescents may accurately self-collect pharyngeal and rectal clinical specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infection

Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer

Suchergebnisse filtern